For generations, employees have been climbing the corporate ladder to be successful — but young workers are over it. According to a new Glassdoor report, Gen Z is beginning to reject the traditional ...

Julian Becerra first learned about retatrutide while scrolling social media. The 24-year-old saw Dawson Weiss, a bodybuilder, post unbelievable photos on TikTok — his muscles rippling, his torso ...

Eli Lilly & Co is partnering with Chinese online healthcare platform JD Health International Inc. to sell its blockbuster drugs for obesity and diabetes online, following in competitors’ footsteps to ...

Eli Lilly is releasing new Phase 3 trial results Tuesday. Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose approximately 23 ...

Novo Nordisk and Eli Lilly both declined significantly in the last months. This was mainly caused by efficacy uncertainty, further competition and political headwinds. Despite the sell-offs, I ...

Despite strong financial results, a recent clinical setback led to a decline in the stock. The company's valuation might continue to be an issue in the near term. However, the drugmaker has excellent ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Eli Lilly (NYSE:LLY) has quickly emerged as one of Wall ...

For more than six decades, Lilly Pulitzer has been synonymous with colorful, eye-catching resortwear, often featuring playful motifs. Several prints have been released over the years, but ahead of ...

A year after earning FDA approval for Kisunla, Eli Lilly is shining a light on the anti-amyloid Alzheimer’s disease therapy in its first branded campaign. The “Light Up Tomorrow” direct-to-consumer ...

Eli Lilly is promoting its Alzheimer’s medication Kisunla with a national ad campaign centered on hope for treating the disease as well as the importance of early detection and screening. Lilly’s ...